SB
Serge Belanger Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
107
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
96.2%
Neutral
3.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $14 |
117%
upside
| 2 | +3.9% |
0
%
| 5 Mar ‘26 2 days ago |
|
|
|
Buy
Maintained
| $54 |
50%
upside
| 2 | +11% |
0
%
| 5 Mar ‘26 2 days ago |
|
|
|
Buy
Maintained
| $40 |
48%
upside
| 1 | +17% |
0
%
| 4 Mar ‘26 3 days ago |
|
|
|
Buy
Maintained
| $5 |
84%
upside
| 1 | +51% |
0
%
| 3 Mar ‘26 3 days ago |
|
|
|
Buy
Maintained
| $58 |
38%
upside
| 1 | +5.8% |
0
%
| 27 Feb ‘26 7 days ago |
|
|
|
Buy
Maintained
| $30 |
55%
upside
| 1 | -7.3% |
0
%
| 27 Feb ‘26 8 days ago |
|
|
|
Buy
Maintained
| $54 |
45%
upside
| 2 | +13% |
0
%
| 26 Feb ‘26 8 days ago |
|
|
|
Buy
Maintained
| $36 |
50%
upside
| 2 | +6.9% |
0
%
| 26 Feb ‘26 9 days ago |
|
|
|
Buy
Reiterated
| $25 |
38%
upside
| 2 | +23% |
0
%
| 26 Feb ‘26 9 days ago |
|
|
|
Buy
Maintained
| $85 |
41%
upside
| 3 | +11% |
0
%
| 25 Feb ‘26 10 days ago |
|
|
|
Buy
Maintained
| $18 |
75%
upside
| 2 | +9.9% |
0
%
| 20 Feb ‘26 15 days ago |
|
|
|
Buy
Maintained
| $48 |
61%
upside
| 1 | +17% |
0
%
| 18 Feb ‘26 16 days ago |
|
|
|
Buy
Reiterated
| $42 |
48%
upside
| 2 | +23% |
0
%
| 4 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $35 |
116%
upside
| 2 | +4.4% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $30 |
36%
upside
| 1 | -0.75% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Hold
Reiterated
| – | – | 1 | +0.7% |
0
%
| 24 Dec ‘25 2 months ago |
|